Ronixone T 250mg/31.25mg Injection
Marketer
Ronish Bioceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ronixone T 250mg/31.25mg Injection
Cefuroxime Axetil and Tinidazole Injection, 250mg/31.25mg, is a dual-action antibiotic. It's indicated for diverse bacterial infections, inhibiting microbial proliferation and halting infection spread. Administration must be under a physician's direct guidance. Consistent adherence to the prescribed dosage is crucial; completing the entire treatment regimen is vital, regardless of symptom improvement. Premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it usually doesn't affect driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Ronixone T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ronixone T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ronixone T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ronixone T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ronixone T 250mg/31.25mg Injection works:
Ronixone T Injection, containing 250mg Ceftriaxone and 31.25mg Tazobactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The beta-lactamase inhibitor, Tazobactam, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Ronixone T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ronixone T (250mg/31.25mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Ronixone T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ronixone T 250mg/31.25mg Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ronixone T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Ronixone T 250mg/31.25mg requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dose of Ronixone T 250mg/31.25mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ronixone T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Ronixone T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Ronixone T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently